Table 3.
Cox proportional-hazards regression analysis with RFS, EFS, and OS as the outcome (n = 256).
Factors | HR | Std Err. | P-value | 95% CI |
---|---|---|---|---|
Short Relapse Free Survival (RFS) | ||||
Age > 10 years | 1.20 | 0.258 | 0.4835 | 0.72–1.98 |
Hyperleukocytosis | 2.49 | 0.258 | 0.0004 | 1.50–4.11 |
Mediastinal mass | 1.10 | 0.286 | 0.7181 | 0.63–1.93 |
ETP-subtype | 0.65 | 0.376 | 0.2493 | 0.31–1.35 |
PIMRD positive status | 5.04 | 0.286 | <0.0001 | 2.89–8.81 |
Short Event Free Survival (EFS) | ||||
Age > 10 years | 0.94 | 0.20 | 0.7756 | 0.63–1.41 |
Hyperleukocytosis | 2.04 | 0.20 | 0.0004 | 1.37–3.03 |
Mediastinal mass | 1.32 | 0.21 | 0.2037 | 0.86–2.01 |
ETP-subtype | 0.73 | 0.32 | 0.3235 | 0.39–1.36 |
PIMRD positive status | 2.22 | 0.20 | 0.0001 | 1.49–3.29 |
Short Overall Survival (OS) | ||||
Age > 10 years | 0.86 | 0.24 | 0.5404 | 0.53–1.31 |
Hyperleukocytosis | 1.90 | 0.23 | 0.0031 | 1.20–2.87 |
Mediastinal mass | 1.40 | 0.24 | 0.1738 | 0.89–2.23 |
ETP-subtype | 1.02 | 0.34 | 0.9477 | 0.45–1.71 |
PIMRD positive status | 1.74 | 0.24 | 0.0184 | 1.26–3.10 |